ULTRALIFE CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $191.2M | $164.5M | $158.6M | $131.8M | $98.3M | $107.7M | $106.8M | $87.2M |
| Cost of Revenue | $145.1M | $122.1M | $119.4M | $102.4M | $73.6M | $78.6M | $75.6M | $61.6M |
| Gross Profit | $46.0M | $42.3M | $39.2M | $29.4M | $24.6M | $29.2M | $31.2M | $25.6M |
| Gross Margin | 24.1% | 25.7% | 24.7% | 22.3% | 25.1% | 27.1% | 29.2% | 29.3% |
| Operating Expenses | ||||||||
| Research & Development | $10.4M | $8.3M | $7.5M | $7.1M | $6.8M | $5.9M | $6.8M | $4.5M |
| SG&A Expense | $29.3M | $24.1M | $22.2M | $22.2M | $17.8M | $17.5M | $17.0M | $14.5M |
| Operating Income | $-5.9M | $10.0M | $9.5M | $129.0K | $35.0K | $5.7M | $7.4M | $6.6M |
| Operating Margin | -3.1% | 6.1% | 6.0% | 0.1% | 0.0% | 5.3% | 6.9% | 7.5% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-8.4M | $8.3M | $9.1M | $-446.0K | $-151.0K | $7.0M | $6.8M | $6.6M |
| Income Tax Expense | $-2.4M | $1.9M | $2.0M | $-326.0K | $79.0K | $1.7M | $1.5M | $-18.4M |
| Net Income | $-5.9M | $6.3M | $7.2M | $-119.0K | $-234.0K | $5.2M | $5.2M | $24.9M |
| Net Margin | -3.1% | 3.8% | 4.5% | -0.1% | -0.2% | 4.9% | 4.9% | 28.6% |
| EPS (Basic) | $-35.00 | $38.00 | $0.44 | $0.05 | $0.05 | $0.33 | $33.00 | $1.57 |
| EPS (Diluted) | $-35.00 | $38.00 | $0.44 | $0.05 | $0.05 | $0.33 | $32.00 | $1.53 |
| Shares Outstanding (Basic) | 16.6M | 16.6M | 16.2M | 16.1M | 16.0M | 15.9M | 15.8M | 15.9M |
| Shares Outstanding (Diluted) | 16.6M | 16.8M | 16.2M | 16.1M | 16.0M | 16.1M | 16.2M | 16.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |